289 related articles for article (PubMed ID: 21803756)
1. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy.
Alter P; Rupp H; Adams P; Stoll F; Figiel JH; Klose KJ; Rominger MB; Maisch B
Eur J Heart Fail; 2011 Sep; 13(9):937-44. PubMed ID: 21803756
[TBL] [Abstract][Full Text] [Related]
2. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
[TBL] [Abstract][Full Text] [Related]
3. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, pattern, and functional impact of late gadolinium enhancement in left ventricular hypertrophy due to aortic valve stenosis.
Nassenstein K; Bruder O; Breuckmann F; Erbel R; Barkhausen J; Schlosser T
Rofo; 2009 May; 181(5):472-6. PubMed ID: 19241322
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.
Soriano CJ; Ridocci F; Estornell J; Jimenez J; Martinez V; De Velasco JA
J Am Coll Cardiol; 2005 Mar; 45(5):743-8. PubMed ID: 15734620
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
7. Fat deposition in dilated cardiomyopathy assessed by CMR.
Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
[TBL] [Abstract][Full Text] [Related]
8. Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure--use of the volume-based wall stress index.
Alter P; Rupp H; Stoll F; Adams P; Figiel JH; Klose KJ; Rominger MB; Maisch B
Int J Cardiol; 2012 May; 157(2):233-8. PubMed ID: 21862155
[TBL] [Abstract][Full Text] [Related]
9. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
[TBL] [Abstract][Full Text] [Related]
11. Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy.
Alter P; Rupp H; Rominger MB; Vollrath A; Czerny F; Klose KJ; Maisch B
Can J Physiol Pharmacol; 2007 Aug; 85(8):790-9. PubMed ID: 17901889
[TBL] [Abstract][Full Text] [Related]
12. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy.
Chaowu Y; Shihua Z; Jian L; Li L; Wei F
Circ Heart Fail; 2013 Sep; 6(5):1013-20. PubMed ID: 23873474
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
[TBL] [Abstract][Full Text] [Related]
15. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.
Latus H; Gummel K; Klingel K; Moysich A; Khalil M; Mazhari N; Bauer J; Kandolf R; Schranz D; Apitz C
J Cardiovasc Magn Reson; 2015 May; 17(1):34. PubMed ID: 25976093
[TBL] [Abstract][Full Text] [Related]
16. Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy.
Dumont CA; Monserrat L; Peteiro J; Soler R; Rodriguez E; Bouzas A; Fernández X; Pérez R; Bouzas B; Castro-Beiras A
Am J Cardiol; 2007 May; 99(10):1454-7. PubMed ID: 17493479
[TBL] [Abstract][Full Text] [Related]
17. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy.
Tateishi E; Noguchi T; Goto Y; Morita Y; Ishibashi-Ueda H; Yamada N; Kanzaki H; Nishimura K; Miyamoto Y; Anzai T; Ogawa H; Yasuda S
Heart; 2015 May; 101(10):774-80. PubMed ID: 25761994
[TBL] [Abstract][Full Text] [Related]
19. Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy.
Doesch C; Streitner F; Bellm S; Suselbeck T; Haghi D; Heggemann F; Schoenberg SO; Michaely H; Borggrefe M; Papavassiliu T
Obesity (Silver Spring); 2013 Mar; 21(3):E253-61. PubMed ID: 23592680
[TBL] [Abstract][Full Text] [Related]
20. Patterns of late gadolinium enhancement are associated with ventricular stiffness in patients with advanced non-ischaemic dilated cardiomyopathy.
Choi EY; Choi BW; Kim SA; Rhee SJ; Shim CY; Kim YJ; Kang SM; Ha JW; Chung N
Eur J Heart Fail; 2009 Jun; 11(6):573-80. PubMed ID: 19383672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
